nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—CYP3A4—Temozolomide—brain cancer	0.21	0.486	CbGbCtD
Etonogestrel—CYP3A4—Lomustine—brain cancer	0.179	0.414	CbGbCtD
Etonogestrel—CYP3A4—Etoposide—brain cancer	0.0432	0.0999	CbGbCtD
Etonogestrel—SHBG—hindbrain—brain cancer	0.00716	0.0901	CbGeAlD
Etonogestrel—PGR—blood vessel—brain cancer	0.00676	0.0851	CbGeAlD
Etonogestrel—PGR—hindbrain—brain cancer	0.00645	0.0812	CbGeAlD
Etonogestrel—ESR1—blood vessel—brain cancer	0.00529	0.0666	CbGeAlD
Etonogestrel—Mestranol—CYP2C9—brain cancer	0.00515	0.538	CrCbGaD
Etonogestrel—ESR1—hindbrain—brain cancer	0.00505	0.0635	CbGeAlD
Etonogestrel—SHBG—brainstem—brain cancer	0.0041	0.0516	CbGeAlD
Etonogestrel—Ethinyl Estradiol—ESR2—brain cancer	0.00313	0.326	CrCbGaD
Etonogestrel—SHBG—gonad—brain cancer	0.00304	0.0383	CbGeAlD
Etonogestrel—SHBG—pituitary gland—brain cancer	0.00297	0.0373	CbGeAlD
Etonogestrel—ESR1—brainstem—brain cancer	0.00289	0.0364	CbGeAlD
Etonogestrel—PGR—pituitary gland—brain cancer	0.00267	0.0336	CbGeAlD
Etonogestrel—ESR1—telencephalon—brain cancer	0.00257	0.0323	CbGeAlD
Etonogestrel—PGR—Nuclear signaling by ERBB4—GFAP—brain cancer	0.00246	0.0481	CbGpPWpGaD
Etonogestrel—Abnormal vision—Carmustine—brain cancer	0.00238	0.00557	CcSEcCtD
Etonogestrel—Anorexia—Lomustine—brain cancer	0.00233	0.00547	CcSEcCtD
Etonogestrel—SHBG—endocrine gland—brain cancer	0.0023	0.0289	CbGeAlD
Etonogestrel—Abnormal vision—Temozolomide—brain cancer	0.0023	0.00538	CcSEcCtD
Etonogestrel—Swelling—Carmustine—brain cancer	0.00224	0.00525	CcSEcCtD
Etonogestrel—Body temperature increased—Carboplatin—brain cancer	0.00221	0.00518	CcSEcCtD
Etonogestrel—Breast disorder—Hydroxyurea—brain cancer	0.00221	0.00518	CcSEcCtD
Etonogestrel—Haemoglobin—Procarbazine—brain cancer	0.0022	0.00515	CcSEcCtD
Etonogestrel—Haemorrhage—Procarbazine—brain cancer	0.00219	0.00512	CcSEcCtD
Etonogestrel—ESR1—gonad—brain cancer	0.00214	0.0269	CbGeAlD
Etonogestrel—Decreased appetite—Lomustine—brain cancer	0.00213	0.00499	CcSEcCtD
Etonogestrel—ESR1—pituitary gland—brain cancer	0.00209	0.0263	CbGeAlD
Etonogestrel—SHBG—central nervous system—brain cancer	0.00207	0.0261	CbGeAlD
Etonogestrel—PGR—endocrine gland—brain cancer	0.00207	0.026	CbGeAlD
Etonogestrel—Hot flush—Temozolomide—brain cancer	0.00204	0.00479	CcSEcCtD
Etonogestrel—PGR—head—brain cancer	0.00204	0.0257	CbGeAlD
Etonogestrel—Menopausal symptoms—Temozolomide—brain cancer	0.00203	0.00475	CcSEcCtD
Etonogestrel—SHBG—cerebellum—brain cancer	0.00202	0.0255	CbGeAlD
Etonogestrel—Dysuria—Hydroxyurea—brain cancer	0.00198	0.00463	CcSEcCtD
Etonogestrel—Body temperature increased—Lomustine—brain cancer	0.00194	0.00453	CcSEcCtD
Etonogestrel—Alopecia—Procarbazine—brain cancer	0.00193	0.00453	CcSEcCtD
Etonogestrel—ESR1—LKB1 signaling events—STRADA—brain cancer	0.00193	0.0376	CbGpPWpGaD
Etonogestrel—Weight increased—Hydroxyurea—brain cancer	0.00193	0.00451	CcSEcCtD
Etonogestrel—Infestation NOS—Hydroxyurea—brain cancer	0.00189	0.00442	CcSEcCtD
Etonogestrel—Infestation—Hydroxyurea—brain cancer	0.00189	0.00442	CcSEcCtD
Etonogestrel—Affect lability—Temozolomide—brain cancer	0.00188	0.00441	CcSEcCtD
Etonogestrel—Tension—Procarbazine—brain cancer	0.00187	0.00438	CcSEcCtD
Etonogestrel—PGR—central nervous system—brain cancer	0.00187	0.0235	CbGeAlD
Etonogestrel—Nervousness—Procarbazine—brain cancer	0.00185	0.00433	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00185	0.00433	CcSEcCtD
Etonogestrel—PGR—Ovarian Infertility Genes—ESR2—brain cancer	0.00183	0.0356	CbGpPWpGaD
Etonogestrel—PGR—cerebellum—brain cancer	0.00182	0.0229	CbGeAlD
Etonogestrel—Mood swings—Temozolomide—brain cancer	0.00181	0.00424	CcSEcCtD
Etonogestrel—Swelling—Etoposide—brain cancer	0.00173	0.00406	CcSEcCtD
Etonogestrel—Breast disorder—Temozolomide—brain cancer	0.00173	0.00405	CcSEcCtD
Etonogestrel—Haemoglobin—Hydroxyurea—brain cancer	0.0017	0.00399	CcSEcCtD
Etonogestrel—Haemorrhage—Hydroxyurea—brain cancer	0.00169	0.00397	CcSEcCtD
Etonogestrel—Abdominal distension—Temozolomide—brain cancer	0.00166	0.0039	CcSEcCtD
Etonogestrel—Cough—Procarbazine—brain cancer	0.00166	0.00389	CcSEcCtD
Etonogestrel—Convulsion—Procarbazine—brain cancer	0.00165	0.00387	CcSEcCtD
Etonogestrel—Hypertension—Procarbazine—brain cancer	0.00164	0.00385	CcSEcCtD
Etonogestrel—SHBG—brain—brain cancer	0.00164	0.0207	CbGeAlD
Etonogestrel—Arthralgia—Procarbazine—brain cancer	0.00162	0.0038	CcSEcCtD
Etonogestrel—Myalgia—Procarbazine—brain cancer	0.00162	0.0038	CcSEcCtD
Etonogestrel—ESR1—endocrine gland—brain cancer	0.00162	0.0204	CbGeAlD
Etonogestrel—Anxiety—Procarbazine—brain cancer	0.00162	0.00378	CcSEcCtD
Etonogestrel—ESR1—head—brain cancer	0.0016	0.0201	CbGeAlD
Etonogestrel—PGR—Nuclear Receptors—ESR2—brain cancer	0.00159	0.031	CbGpPWpGaD
Etonogestrel—Bronchitis—Temozolomide—brain cancer	0.00159	0.00372	CcSEcCtD
Etonogestrel—Vomiting—Lomustine—brain cancer	0.00156	0.00365	CcSEcCtD
Etonogestrel—Oedema—Procarbazine—brain cancer	0.00155	0.00364	CcSEcCtD
Etonogestrel—Dysuria—Temozolomide—brain cancer	0.00155	0.00362	CcSEcCtD
Etonogestrel—Infection—Procarbazine—brain cancer	0.00154	0.00362	CcSEcCtD
Etonogestrel—Angiopathy—Hydroxyurea—brain cancer	0.00154	0.0036	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Temozolomide—brain cancer	0.00154	0.0036	CcSEcCtD
Etonogestrel—Pollakiuria—Temozolomide—brain cancer	0.00153	0.00358	CcSEcCtD
Etonogestrel—Depression—Carmustine—brain cancer	0.00152	0.00356	CcSEcCtD
Etonogestrel—Weight increased—Temozolomide—brain cancer	0.0015	0.00352	CcSEcCtD
Etonogestrel—Alopecia—Hydroxyurea—brain cancer	0.0015	0.0035	CcSEcCtD
Etonogestrel—Weight decreased—Temozolomide—brain cancer	0.0015	0.0035	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Carmustine—brain cancer	0.00149	0.0035	CcSEcCtD
Etonogestrel—Urinary tract infection—Carmustine—brain cancer	0.00148	0.00347	CcSEcCtD
Etonogestrel—Anorexia—Procarbazine—brain cancer	0.00148	0.00347	CcSEcCtD
Etonogestrel—PGR—brain—brain cancer	0.00148	0.0186	CbGeAlD
Etonogestrel—Erythema—Hydroxyurea—brain cancer	0.00147	0.00345	CcSEcCtD
Etonogestrel—Infestation NOS—Temozolomide—brain cancer	0.00147	0.00345	CcSEcCtD
Etonogestrel—Infestation—Temozolomide—brain cancer	0.00147	0.00345	CcSEcCtD
Etonogestrel—Depression—Temozolomide—brain cancer	0.00147	0.00344	CcSEcCtD
Etonogestrel—ESR1—central nervous system—brain cancer	0.00146	0.0184	CbGeAlD
Etonogestrel—Nausea—Lomustine—brain cancer	0.00145	0.00341	CcSEcCtD
Etonogestrel—ESR1—Nuclear signaling by ERBB4—GFAP—brain cancer	0.00145	0.0282	CbGpPWpGaD
Etonogestrel—Neuropathy peripheral—Temozolomide—brain cancer	0.00144	0.00338	CcSEcCtD
Etonogestrel—Urinary tract infection—Temozolomide—brain cancer	0.00143	0.00335	CcSEcCtD
Etonogestrel—ESR1—cerebellum—brain cancer	0.00143	0.0179	CbGeAlD
Etonogestrel—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00142	0.00332	CcSEcCtD
Etonogestrel—Insomnia—Procarbazine—brain cancer	0.00141	0.00329	CcSEcCtD
Etonogestrel—Paraesthesia—Procarbazine—brain cancer	0.0014	0.00327	CcSEcCtD
Etonogestrel—Sinusitis—Temozolomide—brain cancer	0.00138	0.00324	CcSEcCtD
Etonogestrel—Somnolence—Procarbazine—brain cancer	0.00138	0.00324	CcSEcCtD
Etonogestrel—Cramp muscle—Etoposide—brain cancer	0.00138	0.00323	CcSEcCtD
Etonogestrel—Haemoglobin—Carmustine—brain cancer	0.00138	0.00322	CcSEcCtD
Etonogestrel—Haemorrhage—Carmustine—brain cancer	0.00137	0.00321	CcSEcCtD
Etonogestrel—Ill-defined disorder—Hydroxyurea—brain cancer	0.00137	0.0032	CcSEcCtD
Etonogestrel—Hypoaesthesia—Carmustine—brain cancer	0.00136	0.00319	CcSEcCtD
Etonogestrel—Decreased appetite—Procarbazine—brain cancer	0.00135	0.00317	CcSEcCtD
Etonogestrel—Connective tissue disorder—Carmustine—brain cancer	0.00135	0.00315	CcSEcCtD
Etonogestrel—Fatigue—Procarbazine—brain cancer	0.00134	0.00314	CcSEcCtD
Etonogestrel—Haemoglobin—Temozolomide—brain cancer	0.00133	0.00311	CcSEcCtD
Etonogestrel—Malaise—Hydroxyurea—brain cancer	0.00133	0.00311	CcSEcCtD
Etonogestrel—Pain—Procarbazine—brain cancer	0.00133	0.00311	CcSEcCtD
Etonogestrel—Constipation—Procarbazine—brain cancer	0.00133	0.00311	CcSEcCtD
Etonogestrel—Haemorrhage—Temozolomide—brain cancer	0.00132	0.0031	CcSEcCtD
Etonogestrel—Visual impairment—Carmustine—brain cancer	0.00132	0.00309	CcSEcCtD
Etonogestrel—Hypoaesthesia—Temozolomide—brain cancer	0.00132	0.00308	CcSEcCtD
Etonogestrel—Pharyngitis—Temozolomide—brain cancer	0.00131	0.00308	CcSEcCtD
Etonogestrel—Urinary tract disorder—Temozolomide—brain cancer	0.00131	0.00306	CcSEcCtD
Etonogestrel—Testosterone—CYP2C9—brain cancer	0.0013	0.136	CrCbGaD
Etonogestrel—Connective tissue disorder—Temozolomide—brain cancer	0.0013	0.00304	CcSEcCtD
Etonogestrel—Urethral disorder—Temozolomide—brain cancer	0.0013	0.00304	CcSEcCtD
Etonogestrel—Feeling abnormal—Procarbazine—brain cancer	0.00128	0.003	CcSEcCtD
Etonogestrel—Eye disorder—Carmustine—brain cancer	0.00128	0.003	CcSEcCtD
Etonogestrel—Convulsion—Hydroxyurea—brain cancer	0.00128	0.00299	CcSEcCtD
Etonogestrel—Visual impairment—Temozolomide—brain cancer	0.00127	0.00299	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Procarbazine—brain cancer	0.00127	0.00298	CcSEcCtD
Etonogestrel—PGR—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00126	0.0245	CbGpPWpGaD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00125	0.00292	CcSEcCtD
Etonogestrel—Discomfort—Hydroxyurea—brain cancer	0.00124	0.0029	CcSEcCtD
Etonogestrel—Eye disorder—Temozolomide—brain cancer	0.00124	0.0029	CcSEcCtD
Etonogestrel—Urticaria—Procarbazine—brain cancer	0.00123	0.00289	CcSEcCtD
Etonogestrel—Body temperature increased—Procarbazine—brain cancer	0.00123	0.00288	CcSEcCtD
Etonogestrel—Abdominal pain—Procarbazine—brain cancer	0.00123	0.00288	CcSEcCtD
Etonogestrel—Alopecia—Carmustine—brain cancer	0.00121	0.00283	CcSEcCtD
Etonogestrel—Oedema—Hydroxyurea—brain cancer	0.0012	0.00282	CcSEcCtD
Etonogestrel—Angiopathy—Temozolomide—brain cancer	0.0012	0.00281	CcSEcCtD
Etonogestrel—Mental disorder—Carmustine—brain cancer	0.0012	0.00281	CcSEcCtD
Etonogestrel—Infection—Hydroxyurea—brain cancer	0.0012	0.0028	CcSEcCtD
Etonogestrel—Immune system disorder—Temozolomide—brain cancer	0.00119	0.0028	CcSEcCtD
Etonogestrel—Erythema—Carmustine—brain cancer	0.00119	0.00279	CcSEcCtD
Etonogestrel—Malnutrition—Carmustine—brain cancer	0.00119	0.00279	CcSEcCtD
Etonogestrel—Nervous system disorder—Hydroxyurea—brain cancer	0.00118	0.00276	CcSEcCtD
Etonogestrel—Infestation—Etoposide—brain cancer	0.00118	0.00276	CcSEcCtD
Etonogestrel—Infestation NOS—Etoposide—brain cancer	0.00118	0.00276	CcSEcCtD
Etonogestrel—Alopecia—Temozolomide—brain cancer	0.00117	0.00274	CcSEcCtD
Etonogestrel—Skin disorder—Hydroxyurea—brain cancer	0.00117	0.00274	CcSEcCtD
Etonogestrel—Mental disorder—Temozolomide—brain cancer	0.00116	0.00271	CcSEcCtD
Etonogestrel—ESR1—brain—brain cancer	0.00116	0.0146	CbGeAlD
Etonogestrel—Neuropathy peripheral—Etoposide—brain cancer	0.00116	0.00271	CcSEcCtD
Etonogestrel—Back pain—Carmustine—brain cancer	0.00115	0.0027	CcSEcCtD
Etonogestrel—Malnutrition—Temozolomide—brain cancer	0.00115	0.0027	CcSEcCtD
Etonogestrel—Erythema—Temozolomide—brain cancer	0.00115	0.0027	CcSEcCtD
Etonogestrel—Anorexia—Hydroxyurea—brain cancer	0.00115	0.00269	CcSEcCtD
Etonogestrel—Hypersensitivity—Procarbazine—brain cancer	0.00115	0.00268	CcSEcCtD
Etonogestrel—Asthenia—Procarbazine—brain cancer	0.00112	0.00261	CcSEcCtD
Etonogestrel—Back pain—Temozolomide—brain cancer	0.00111	0.00261	CcSEcCtD
Etonogestrel—PGR—Ovarian Infertility Genes—CDK4—brain cancer	0.00111	0.0217	CbGpPWpGaD
Etonogestrel—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.0011	0.0215	CbGpPWpGaD
Etonogestrel—Pruritus—Procarbazine—brain cancer	0.0011	0.00258	CcSEcCtD
Etonogestrel—Somnolence—Hydroxyurea—brain cancer	0.00107	0.00251	CcSEcCtD
Etonogestrel—Ill-defined disorder—Temozolomide—brain cancer	0.00107	0.0025	CcSEcCtD
Etonogestrel—Diarrhoea—Procarbazine—brain cancer	0.00106	0.00249	CcSEcCtD
Etonogestrel—Dyspepsia—Hydroxyurea—brain cancer	0.00106	0.00248	CcSEcCtD
Etonogestrel—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00106	0.0206	CbGpPWpGaD
Etonogestrel—Hypoaesthesia—Etoposide—brain cancer	0.00105	0.00247	CcSEcCtD
Etonogestrel—Angioedema—Temozolomide—brain cancer	0.00105	0.00246	CcSEcCtD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—ESR2—brain cancer	0.00105	0.0205	CbGpPWpGaD
Etonogestrel—Decreased appetite—Hydroxyurea—brain cancer	0.00105	0.00245	CcSEcCtD
Etonogestrel—Urinary tract disorder—Etoposide—brain cancer	0.00105	0.00245	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00104	0.00243	CcSEcCtD
Etonogestrel—Malaise—Temozolomide—brain cancer	0.00104	0.00243	CcSEcCtD
Etonogestrel—ESR1—FOXA1 transcription factor network—SHH—brain cancer	0.00104	0.0203	CbGpPWpGaD
Etonogestrel—Urethral disorder—Etoposide—brain cancer	0.00104	0.00243	CcSEcCtD
Etonogestrel—Fatigue—Hydroxyurea—brain cancer	0.00104	0.00243	CcSEcCtD
Etonogestrel—Convulsion—Carmustine—brain cancer	0.00103	0.00242	CcSEcCtD
Etonogestrel—Hypertension—Carmustine—brain cancer	0.00103	0.00241	CcSEcCtD
Etonogestrel—Pain—Hydroxyurea—brain cancer	0.00103	0.00241	CcSEcCtD
Etonogestrel—Constipation—Hydroxyurea—brain cancer	0.00103	0.00241	CcSEcCtD
Etonogestrel—Dizziness—Procarbazine—brain cancer	0.00103	0.00241	CcSEcCtD
Etonogestrel—ESR1—FOXM1 transcription factor network—SKP2—brain cancer	0.00102	0.0199	CbGpPWpGaD
Etonogestrel—Myalgia—Carmustine—brain cancer	0.00101	0.00238	CcSEcCtD
Etonogestrel—Anxiety—Carmustine—brain cancer	0.00101	0.00237	CcSEcCtD
Etonogestrel—Cough—Temozolomide—brain cancer	0.001	0.00235	CcSEcCtD
Etonogestrel—Convulsion—Temozolomide—brain cancer	0.000998	0.00234	CcSEcCtD
Etonogestrel—Hypertension—Temozolomide—brain cancer	0.000994	0.00233	CcSEcCtD
Etonogestrel—Feeling abnormal—Hydroxyurea—brain cancer	0.000991	0.00232	CcSEcCtD
Etonogestrel—Eye disorder—Etoposide—brain cancer	0.000989	0.00232	CcSEcCtD
Etonogestrel—Vomiting—Procarbazine—brain cancer	0.000988	0.00231	CcSEcCtD
Etonogestrel—Myalgia—Temozolomide—brain cancer	0.00098	0.0023	CcSEcCtD
Etonogestrel—Arthralgia—Temozolomide—brain cancer	0.00098	0.0023	CcSEcCtD
Etonogestrel—Rash—Procarbazine—brain cancer	0.00098	0.0023	CcSEcCtD
Etonogestrel—Dermatitis—Procarbazine—brain cancer	0.000979	0.00229	CcSEcCtD
Etonogestrel—Anxiety—Temozolomide—brain cancer	0.000977	0.00229	CcSEcCtD
Etonogestrel—Headache—Procarbazine—brain cancer	0.000974	0.00228	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000974	0.00228	CcSEcCtD
Etonogestrel—Oedema—Carmustine—brain cancer	0.000973	0.00228	CcSEcCtD
Etonogestrel—Discomfort—Temozolomide—brain cancer	0.000969	0.00227	CcSEcCtD
Etonogestrel—Infection—Carmustine—brain cancer	0.000966	0.00226	CcSEcCtD
Etonogestrel—Angiopathy—Etoposide—brain cancer	0.00096	0.00225	CcSEcCtD
Etonogestrel—Immune system disorder—Etoposide—brain cancer	0.000956	0.00224	CcSEcCtD
Etonogestrel—Body temperature increased—Hydroxyurea—brain cancer	0.000951	0.00223	CcSEcCtD
Etonogestrel—Oedema—Temozolomide—brain cancer	0.00094	0.0022	CcSEcCtD
Etonogestrel—Anaphylactic shock—Temozolomide—brain cancer	0.00094	0.0022	CcSEcCtD
Etonogestrel—Alopecia—Etoposide—brain cancer	0.000935	0.00219	CcSEcCtD
Etonogestrel—ESR1—Nuclear Receptors—ESR2—brain cancer	0.000934	0.0182	CbGpPWpGaD
Etonogestrel—Infection—Temozolomide—brain cancer	0.000934	0.00219	CcSEcCtD
Etonogestrel—Anorexia—Carmustine—brain cancer	0.000927	0.00217	CcSEcCtD
Etonogestrel—Nausea—Procarbazine—brain cancer	0.000923	0.00216	CcSEcCtD
Etonogestrel—Nervous system disorder—Temozolomide—brain cancer	0.000922	0.00216	CcSEcCtD
Etonogestrel—Skin disorder—Temozolomide—brain cancer	0.000913	0.00214	CcSEcCtD
Etonogestrel—CYP3A4—endocrine gland—brain cancer	0.000903	0.0114	CbGeAlD
Etonogestrel—Anorexia—Temozolomide—brain cancer	0.000896	0.0021	CcSEcCtD
Etonogestrel—Back pain—Etoposide—brain cancer	0.000891	0.00209	CcSEcCtD
Etonogestrel—Hypersensitivity—Hydroxyurea—brain cancer	0.000886	0.00208	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Carmustine—brain cancer	0.000886	0.00208	CcSEcCtD
Etonogestrel—Muscle spasms—Etoposide—brain cancer	0.000886	0.00208	CcSEcCtD
Etonogestrel—Insomnia—Carmustine—brain cancer	0.00088	0.00206	CcSEcCtD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—ESR2—brain cancer	0.000879	0.0171	CbGpPWpGaD
Etonogestrel—Paraesthesia—Carmustine—brain cancer	0.000873	0.00205	CcSEcCtD
Etonogestrel—Somnolence—Carmustine—brain cancer	0.000865	0.00203	CcSEcCtD
Etonogestrel—Asthenia—Hydroxyurea—brain cancer	0.000863	0.00202	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000856	0.00201	CcSEcCtD
Etonogestrel—Ill-defined disorder—Etoposide—brain cancer	0.000855	0.002	CcSEcCtD
Etonogestrel—Insomnia—Temozolomide—brain cancer	0.00085	0.00199	CcSEcCtD
Etonogestrel—Decreased appetite—Carmustine—brain cancer	0.000845	0.00198	CcSEcCtD
Etonogestrel—Paraesthesia—Temozolomide—brain cancer	0.000844	0.00198	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Carmustine—brain cancer	0.00084	0.00197	CcSEcCtD
Etonogestrel—Somnolence—Temozolomide—brain cancer	0.000836	0.00196	CcSEcCtD
Etonogestrel—Pain—Carmustine—brain cancer	0.000832	0.00195	CcSEcCtD
Etonogestrel—Constipation—Carmustine—brain cancer	0.000832	0.00195	CcSEcCtD
Etonogestrel—Malaise—Etoposide—brain cancer	0.000831	0.00195	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—GFAP—brain cancer	0.00083	0.0162	CbGpPWpGaD
Etonogestrel—Dyspepsia—Temozolomide—brain cancer	0.000827	0.00194	CcSEcCtD
Etonogestrel—Diarrhoea—Hydroxyurea—brain cancer	0.000823	0.00193	CcSEcCtD
Etonogestrel—Decreased appetite—Temozolomide—brain cancer	0.000817	0.00191	CcSEcCtD
Etonogestrel—CYP3A4—central nervous system—brain cancer	0.000814	0.0102	CbGeAlD
Etonogestrel—Gastrointestinal disorder—Temozolomide—brain cancer	0.000811	0.0019	CcSEcCtD
Etonogestrel—Fatigue—Temozolomide—brain cancer	0.00081	0.0019	CcSEcCtD
Etonogestrel—Cough—Etoposide—brain cancer	0.000804	0.00188	CcSEcCtD
Etonogestrel—Constipation—Temozolomide—brain cancer	0.000804	0.00188	CcSEcCtD
Etonogestrel—Pain—Temozolomide—brain cancer	0.000804	0.00188	CcSEcCtD
Etonogestrel—Feeling abnormal—Carmustine—brain cancer	0.000801	0.00188	CcSEcCtD
Etonogestrel—Convulsion—Etoposide—brain cancer	0.000798	0.00187	CcSEcCtD
Etonogestrel—Hypertension—Etoposide—brain cancer	0.000796	0.00186	CcSEcCtD
Etonogestrel—Dizziness—Hydroxyurea—brain cancer	0.000796	0.00186	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Carmustine—brain cancer	0.000795	0.00186	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000779	0.00182	CcSEcCtD
Etonogestrel—Discomfort—Etoposide—brain cancer	0.000775	0.00182	CcSEcCtD
Etonogestrel—Feeling abnormal—Temozolomide—brain cancer	0.000774	0.00181	CcSEcCtD
Etonogestrel—Body temperature increased—Carmustine—brain cancer	0.000769	0.0018	CcSEcCtD
Etonogestrel—Abdominal pain—Carmustine—brain cancer	0.000769	0.0018	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Temozolomide—brain cancer	0.000769	0.0018	CcSEcCtD
Etonogestrel—Vomiting—Hydroxyurea—brain cancer	0.000765	0.00179	CcSEcCtD
Etonogestrel—Rash—Hydroxyurea—brain cancer	0.000759	0.00178	CcSEcCtD
Etonogestrel—Dermatitis—Hydroxyurea—brain cancer	0.000758	0.00178	CcSEcCtD
Etonogestrel—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000755	0.0147	CbGpPWpGaD
Etonogestrel—Headache—Hydroxyurea—brain cancer	0.000754	0.00177	CcSEcCtD
Etonogestrel—Anaphylactic shock—Etoposide—brain cancer	0.000752	0.00176	CcSEcCtD
Etonogestrel—ESR1—Estrogen Receptor Pathway—STAT3—brain cancer	0.000748	0.0146	CbGpPWpGaD
Etonogestrel—Infection—Etoposide—brain cancer	0.000747	0.00175	CcSEcCtD
Etonogestrel—Urticaria—Temozolomide—brain cancer	0.000747	0.00175	CcSEcCtD
Etonogestrel—Body temperature increased—Temozolomide—brain cancer	0.000743	0.00174	CcSEcCtD
Etonogestrel—Abdominal pain—Temozolomide—brain cancer	0.000743	0.00174	CcSEcCtD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—PCNA—brain cancer	0.000739	0.0144	CbGpPWpGaD
Etonogestrel—ESR1—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000738	0.0144	CbGpPWpGaD
Etonogestrel—Skin disorder—Etoposide—brain cancer	0.00073	0.00171	CcSEcCtD
Etonogestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00072	0.014	CbGpPWpGaD
Etonogestrel—Anorexia—Etoposide—brain cancer	0.000717	0.00168	CcSEcCtD
Etonogestrel—Hypersensitivity—Carmustine—brain cancer	0.000717	0.00168	CcSEcCtD
Etonogestrel—Nausea—Hydroxyurea—brain cancer	0.000715	0.00167	CcSEcCtD
Etonogestrel—ESR1—FOXM1 transcription factor network—BRCA2—brain cancer	0.000708	0.0138	CbGpPWpGaD
Etonogestrel—Asthenia—Carmustine—brain cancer	0.000698	0.00163	CcSEcCtD
Etonogestrel—Hypersensitivity—Temozolomide—brain cancer	0.000692	0.00162	CcSEcCtD
Etonogestrel—ESR1—FOXM1 transcription factor network—CCNE1—brain cancer	0.000686	0.0134	CbGpPWpGaD
Etonogestrel—Paraesthesia—Etoposide—brain cancer	0.000675	0.00158	CcSEcCtD
Etonogestrel—Asthenia—Temozolomide—brain cancer	0.000674	0.00158	CcSEcCtD
Etonogestrel—Somnolence—Etoposide—brain cancer	0.000669	0.00157	CcSEcCtD
Etonogestrel—Diarrhoea—Carmustine—brain cancer	0.000665	0.00156	CcSEcCtD
Etonogestrel—Pruritus—Temozolomide—brain cancer	0.000665	0.00156	CcSEcCtD
Etonogestrel—Decreased appetite—Etoposide—brain cancer	0.000654	0.00153	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Etoposide—brain cancer	0.000649	0.00152	CcSEcCtD
Etonogestrel—Fatigue—Etoposide—brain cancer	0.000648	0.00152	CcSEcCtD
Etonogestrel—Dizziness—Carmustine—brain cancer	0.000643	0.00151	CcSEcCtD
Etonogestrel—Pain—Etoposide—brain cancer	0.000643	0.00151	CcSEcCtD
Etonogestrel—Constipation—Etoposide—brain cancer	0.000643	0.00151	CcSEcCtD
Etonogestrel—Diarrhoea—Temozolomide—brain cancer	0.000643	0.00151	CcSEcCtD
Etonogestrel—Dizziness—Temozolomide—brain cancer	0.000621	0.00146	CcSEcCtD
Etonogestrel—Feeling abnormal—Etoposide—brain cancer	0.00062	0.00145	CcSEcCtD
Etonogestrel—Vomiting—Carmustine—brain cancer	0.000618	0.00145	CcSEcCtD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—ESR2—brain cancer	0.000616	0.012	CbGpPWpGaD
Etonogestrel—Gastrointestinal pain—Etoposide—brain cancer	0.000615	0.00144	CcSEcCtD
Etonogestrel—Rash—Carmustine—brain cancer	0.000613	0.00144	CcSEcCtD
Etonogestrel—Dermatitis—Carmustine—brain cancer	0.000613	0.00143	CcSEcCtD
Etonogestrel—Headache—Carmustine—brain cancer	0.000609	0.00143	CcSEcCtD
Etonogestrel—Vomiting—Temozolomide—brain cancer	0.000598	0.0014	CcSEcCtD
Etonogestrel—Urticaria—Etoposide—brain cancer	0.000597	0.0014	CcSEcCtD
Etonogestrel—Abdominal pain—Etoposide—brain cancer	0.000595	0.00139	CcSEcCtD
Etonogestrel—Body temperature increased—Etoposide—brain cancer	0.000595	0.00139	CcSEcCtD
Etonogestrel—Rash—Temozolomide—brain cancer	0.000593	0.00139	CcSEcCtD
Etonogestrel—Dermatitis—Temozolomide—brain cancer	0.000592	0.00139	CcSEcCtD
Etonogestrel—Headache—Temozolomide—brain cancer	0.000589	0.00138	CcSEcCtD
Etonogestrel—Nausea—Carmustine—brain cancer	0.000578	0.00135	CcSEcCtD
Etonogestrel—Nausea—Temozolomide—brain cancer	0.000558	0.00131	CcSEcCtD
Etonogestrel—Hypersensitivity—Etoposide—brain cancer	0.000554	0.0013	CcSEcCtD
Etonogestrel—Asthenia—Etoposide—brain cancer	0.00054	0.00126	CcSEcCtD
Etonogestrel—Pruritus—Etoposide—brain cancer	0.000532	0.00125	CcSEcCtD
Etonogestrel—ESR1—FOXM1 transcription factor network—CDK4—brain cancer	0.000525	0.0102	CbGpPWpGaD
Etonogestrel—Diarrhoea—Etoposide—brain cancer	0.000515	0.00121	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—HES1—brain cancer	0.00051	0.00995	CbGpPWpGaD
Etonogestrel—Dizziness—Etoposide—brain cancer	0.000497	0.00116	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—GFAP—brain cancer	0.000487	0.0095	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—PDGFRA—brain cancer	0.000486	0.00948	CbGpPWpGaD
Etonogestrel—Vomiting—Etoposide—brain cancer	0.000478	0.00112	CcSEcCtD
Etonogestrel—Rash—Etoposide—brain cancer	0.000474	0.00111	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—VAV1—brain cancer	0.000474	0.00925	CbGpPWpGaD
Etonogestrel—Dermatitis—Etoposide—brain cancer	0.000474	0.00111	CcSEcCtD
Etonogestrel—Headache—Etoposide—brain cancer	0.000471	0.0011	CcSEcCtD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000457	0.00891	CbGpPWpGaD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000451	0.0088	CbGpPWpGaD
Etonogestrel—Nausea—Etoposide—brain cancer	0.000447	0.00105	CcSEcCtD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—PCNA—brain cancer	0.000434	0.00846	CbGpPWpGaD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—CCND1—brain cancer	0.000412	0.00805	CbGpPWpGaD
Etonogestrel—ESR1—FOXM1 transcription factor network—CDKN2A—brain cancer	0.000401	0.00783	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—CDK4—brain cancer	0.0004	0.00781	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—PDGFRA—brain cancer	0.000388	0.00757	CbGpPWpGaD
Etonogestrel—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000388	0.00757	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00037	0.00723	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000359	0.00701	CbGpPWpGaD
Etonogestrel—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000344	0.00671	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—IRS2—brain cancer	0.000341	0.00665	CbGpPWpGaD
Etonogestrel—ESR1—FOXM1 transcription factor network—CCND1—brain cancer	0.000339	0.00662	CbGpPWpGaD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—MYC—brain cancer	0.000331	0.00645	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000321	0.00626	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000311	0.00606	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000304	0.00593	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—VAV1—brain cancer	0.000278	0.00543	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000275	0.00536	CbGpPWpGaD
Etonogestrel—ESR1—FOXM1 transcription factor network—MYC—brain cancer	0.000272	0.00531	CbGpPWpGaD
Etonogestrel—ESR1—LKB1 signaling events—MYC—brain cancer	0.000267	0.00521	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—CDKN2A—brain cancer	0.000267	0.0052	CbGpPWpGaD
Etonogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	0.000258	0.00504	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—CCND1—brain cancer	0.000258	0.00504	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000257	0.00501	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—OR14C36—brain cancer	0.000256	0.00499	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—OR4C12—brain cancer	0.000256	0.00499	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000254	0.00496	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000253	0.00493	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000249	0.00487	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000247	0.00483	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—RELA—brain cancer	0.000243	0.00474	CbGpPWpGaD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—brain cancer	0.000242	0.00472	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—ERBB2—brain cancer	0.000241	0.00471	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—IL2—brain cancer	0.000237	0.00462	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—ERBB2—brain cancer	0.000234	0.00456	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—IL2—brain cancer	0.000231	0.00451	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—CCND1—brain cancer	0.000231	0.0045	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PDGFRA—brain cancer	0.000228	0.00444	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—CCND1—brain cancer	0.000225	0.0044	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—CTNNB1—brain cancer	0.000223	0.00435	CbGpPWpGaD
Etonogestrel—ESR1—LKB1 signaling events—TP53—brain cancer	0.000219	0.00428	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—DTX2—brain cancer	0.000218	0.00425	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—ESR2—brain cancer	0.000217	0.00424	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—CCND1—brain cancer	0.000213	0.00416	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000211	0.00411	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000207	0.00403	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—NOTCH2—brain cancer	0.000206	0.00401	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000204	0.00398	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—IRS2—brain cancer	0.0002	0.0039	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000197	0.00384	CbGpPWpGaD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—MYC—brain cancer	0.000194	0.00379	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000194	0.00379	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.00019	0.0037	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000189	0.00368	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—MYC—brain cancer	0.000185	0.00361	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—STAT3—brain cancer	0.000184	0.00359	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—EGFR—brain cancer	0.000181	0.00353	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000181	0.00353	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—MYC—brain cancer	0.000181	0.00353	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTCH2—brain cancer	0.000165	0.00322	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—EGFR—brain cancer	0.000162	0.00316	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000161	0.00314	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HES5—brain cancer	0.00016	0.00312	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000156	0.00305	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—STRADA—brain cancer	0.000155	0.00303	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—OR4C12—brain cancer	0.00015	0.00293	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—OR14C36—brain cancer	0.00015	0.00293	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—TP53—brain cancer	0.000148	0.0029	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000147	0.00287	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—ERBB2—brain cancer	0.000137	0.00268	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ABR—brain cancer	0.000129	0.00253	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—DTX2—brain cancer	0.000128	0.00249	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—ESR2—brain cancer	0.000128	0.00249	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GLI2—brain cancer	0.000125	0.00244	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000122	0.00238	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—NOTCH2—brain cancer	0.000121	0.00236	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000121	0.00235	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GLI1—brain cancer	0.000118	0.00229	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—DNMT1—brain cancer	0.000117	0.00227	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000114	0.00223	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SUFU—brain cancer	0.000111	0.00217	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GFAP—brain cancer	0.000108	0.0021	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000106	0.00207	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—ESR2—brain cancer	0.000105	0.00204	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HEY1—brain cancer	0.000102	0.00199	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000101	0.00197	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.0001	0.00195	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—DLL1—brain cancer	0.0001	0.00195	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—NOTCH2—brain cancer	9.91e-05	0.00193	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MYC—brain cancer	9.77e-05	0.00191	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTCH2—brain cancer	9.68e-05	0.00189	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—brain cancer	9.56e-05	0.00186	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—EGFR—brain cancer	9.51e-05	0.00185	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HES5—brain cancer	9.38e-05	0.00183	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—STRADA—brain cancer	9.1e-05	0.00178	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	8.8e-05	0.00172	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SHH—brain cancer	8.5e-05	0.00166	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—SIRT1—brain cancer	8.42e-05	0.00164	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TRPC6—brain cancer	8.2e-05	0.0016	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	8.1e-05	0.00158	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTCH1—brain cancer	8.06e-05	0.00157	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SMO—brain cancer	8.06e-05	0.00157	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—brain cancer	8.02e-05	0.00157	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	7.92e-05	0.00155	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ABR—brain cancer	7.6e-05	0.00148	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GLI2—brain cancer	7.34e-05	0.00143	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GLI1—brain cancer	6.9e-05	0.00135	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—MYC—brain cancer	6.85e-05	0.00134	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—DNMT1—brain cancer	6.84e-05	0.00133	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	6.65e-05	0.0013	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SUFU—brain cancer	6.54e-05	0.00128	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NOTCH2—brain cancer	6.44e-05	0.00126	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GFAP—brain cancer	6.31e-05	0.00123	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VAV1—brain cancer	6.14e-05	0.0012	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—ESR2—brain cancer	6.14e-05	0.0012	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HEY1—brain cancer	5.98e-05	0.00117	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—DLL1—brain cancer	5.87e-05	0.00114	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NOTCH2—brain cancer	5.81e-05	0.00113	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HES1—brain cancer	5.28e-05	0.00103	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PDGFRA—brain cancer	5.03e-05	0.000981	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SHH—brain cancer	4.99e-05	0.000973	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—SIRT1—brain cancer	4.94e-05	0.000964	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SPP1—brain cancer	4.88e-05	0.000952	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TRPC6—brain cancer	4.81e-05	0.000938	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTCH1—brain cancer	4.73e-05	0.000922	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SMO—brain cancer	4.73e-05	0.000922	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IRS2—brain cancer	4.41e-05	0.000861	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—MYC—brain cancer	4.02e-05	0.000785	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APC—brain cancer	3.9e-05	0.000761	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CG—brain cancer	3.9e-05	0.000761	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NOTCH2—brain cancer	3.78e-05	0.000737	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VAV1—brain cancer	3.6e-05	0.000703	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP2C9—brain cancer	3.36e-05	0.000656	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MYC—brain cancer	3.3e-05	0.000644	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HES1—brain cancer	3.1e-05	0.000605	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—RELA—brain cancer	3.05e-05	0.000594	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ERBB2—brain cancer	3.03e-05	0.000591	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PDGFRA—brain cancer	2.95e-05	0.000576	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SPP1—brain cancer	2.86e-05	0.000559	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—BSG—brain cancer	2.86e-05	0.000558	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL2—brain cancer	2.74e-05	0.000535	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCND1—brain cancer	2.67e-05	0.000522	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CTNNB1—brain cancer	2.65e-05	0.000517	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IRS2—brain cancer	2.59e-05	0.000505	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—IDH1—brain cancer	2.46e-05	0.00048	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VEGFA—brain cancer	2.33e-05	0.000455	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—STAT3—brain cancer	2.31e-05	0.00045	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APC—brain cancer	2.29e-05	0.000446	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CG—brain cancer	2.29e-05	0.000446	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MYC—brain cancer	2.15e-05	0.000419	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EGFR—brain cancer	2.1e-05	0.000409	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ENO2—brain cancer	1.94e-05	0.000379	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MYC—brain cancer	1.94e-05	0.000378	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RELA—brain cancer	1.79e-05	0.000349	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ERBB2—brain cancer	1.78e-05	0.000347	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TP53—brain cancer	1.76e-05	0.000344	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL2—brain cancer	1.61e-05	0.000314	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCND1—brain cancer	1.57e-05	0.000306	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CTNNB1—brain cancer	1.55e-05	0.000303	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VEGFA—brain cancer	1.37e-05	0.000267	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—STAT3—brain cancer	1.36e-05	0.000264	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MYC—brain cancer	1.26e-05	0.000246	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EGFR—brain cancer	1.23e-05	0.00024	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TP53—brain cancer	1.03e-05	0.000202	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CG—brain cancer	8.92e-06	0.000174	CbGpPWpGaD
